My research interests have been in cardiovascular development and disease, immune and vascular cell network, angiogenesis, acetylosome, and mouse genomics. With my experiences and scientific achievements, I had served the Review Board of Expert Committee on Life Science and Welfare, National Science and Technology Council and President of Korean Society for Vascular Biology and Medicine. I have initiated the foundation of Ewha Laboratory Animal Genomic Center and developed novel transgenic and knockout mouse models of human disease such as atherosclerosis (CD137, Ninj1, Retnla, Oasl1), and Ogden syndrome (Naa10). With scientific knowledge and insight from immune and vascular cell network research, my new research will be extended to study on the cellular function and molecular mechanism in the immune system that mediates the heart-to-brain bidirectional interaction network. This will provide a new paradigm to develop the therapeutical strategy by elucidating the physiopathological cause of cardio-cerebrovascular diseases in myocardial infarction and stroke mouse models.

PhD in Pharmacological Biomolecular Sciences, Experimental and Clinical, I am a Biostatistician with proven experience in cardiovascular disease and associated risk factors epidemiology analysis

Onea H-L is a 6th year cardiology fellow and PhD candidate at the Iuliu Hatieganu University of Medicine and Pharmacy Cluj- Napoca, Romania. He has a deep interest for research and developing practical skills in the field of interventional cardiology.

I am currently a Research Fellow and we are working towards the development of analytics to aid in cardiovascular disease treatment and management. Prior to this, I have completed my Ph.D and was working on elucidating the role of gelsolin, a cytoskeletal protein in Wnt signaling in colorectal cancer. Key focus: Spheroid model and disease application

Katariina Öörni leads the Atherosclerosis Research Laboratory at the Wihuri Research Institute in Helsinki, Finland. Her research interests are related to plasma lipoproteins and their role in atherogenesis.

Reindert F. Oostveen MSc, MD, is a PhD student at the Vascular Department of the Amsterdam UMC, affiliated with the University of Amsterdam. His research focuses on imaging of vascular inflammation, under supervision of Prof. Stroes and Prof. Hovingh.

Carl E. Orringer, MD, FACC, FNLA is a Professor of Medicine at the University of Miami Miller School of Medicine, Miami, Florida and Director of the Preventive Cardiovascular Medicine Program for the University of Miami Health System. He was the first recipient of the Harrington Chair in Preventive Cardiovascular Medicine at University Hospitals Case Medical Center in Cleveland, Ohio. He is a past president and fellow of the National Lipid Association. He has served as Editor-in-Chief of three editions of the National Lipid Association Self-Assessment Program and is the author of the Lipid Management section of the American College of Cardiology Self Assessment Program through 2023. He is a fellow of the American College of Cardiology and is a co-author of American College of Cardiology Expert Consensus Decision Pathway documents on the Management of Hypertriglyceridemia in 2021 and on Non-Statin Therapies in 2022. He served as a member of Writing Committee of the 2018 American Heart Association/ACC/Multi-Society Guideline on the Treatment of Blood Cholesterol and has authored or co-authored multiple National Lipid Association Scientific Statements. He is an Associate Editor of the European Heart Journal.